Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Scholar Rock
< Previous
1
2
3
4
5
Next >
Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
November 03, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
November 02, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023
October 23, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRK
Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting
October 19, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders
October 11, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial
September 19, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 15, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress
August 09, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 13, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 15, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present at the Jefferies Healthcare Conference
June 01, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference
May 08, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors
April 10, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress
March 07, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 01, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
February 06, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Provides Corporate Update and Highlights Priorities for 2023
January 09, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress
November 14, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy
November 10, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.